A citation-based method for searching scientific literature

Livnat Jerby-Arnon, Parin Shah, Michael S Cuoco, Christopher Rodman, Mei-Ju Su, Johannes C Melms, Rachel Leeson, Abhay Kanodia, Shaolin Mei, Jia-Ren Lin, Shu Wang, Bokang Rabasha, David Liu, Gao Zhang, Claire Margolais, Orr Ashenberg, Patrick A Ott, Elizabeth I Buchbinder, Rizwan Haq, F Stephen Hodi, Genevieve M Boland, Ryan J Sullivan, Dennie T Frederick, Benchun Miao, Tabea Moll, Keith T Flaherty, Meenhard Herlyn, Russell W Jenkins, Rohit Thummalapalli, Monika S Kowalczyk, Israel Cañadas, Bastian Schilling, Adam N R Cartwright, Adrienne M Luoma, Shruti Malu, Patrick Hwu, Chantale Bernatchez, Marie-Andrée Forget, David A Barbie, Alex K Shalek, Itay Tirosh, Peter K Sorger, Kai Wucherpfennig, Eliezer M Van Allen, Dirk Schadendorf, Bruce E Johnson, Asaf Rotem, Orit Rozenblatt-Rosen, Levi A Garraway, Charles H Yoon, Benjamin Izar, Aviv Regev. Cell 2018
Times Cited: 323



Roy S Herbst, Jean-Charles Soria, Marcin Kowanetz, Gregg D Fine, Omid Hamid, Michael S Gordon, Jeffery A Sosman, David F McDermott, John D Powderly, Scott N Gettinger, Holbrook E K Kohrt, Leora Horn, Donald P Lawrence, Sandra Rost, Maya Leabman, Yuanyuan Xiao, Ahmad Mokatrin, Hartmut Koeppen, Priti S Hegde, Ira Mellman, Daniel S Chen, F Stephen Hodi. Nature 2014
Times Cited: 2988




List of shared articles



Times cited

Addressing resistance to immune checkpoint inhibitor therapy: an urgent unmet need.
Siwen Hu-Lieskovan, Gabriel G Malouf, Ira Jacobs, Jeffrey Chou, Li Liu, Melissa L Johnson. Future Oncol 2021
2

Single-cell transcriptome analysis of the heterogeneous effects of differential expression of tumor PD-L1 on responding TCR-T cells.
Renpeng Ding, Shang Liu, Shanshan Wang, Huanyi Chen, Fei Wang, Qumiao Xu, Linnan Zhu, Xuan Dong, Ying Gu, Xiuqing Zhang,[...]. Theranostics 2021
0

Advanced Melanoma: Resistance Mechanisms to Current Therapies.
Alexandra M Haugh, April K S Salama, Douglas B Johnson. Hematol Oncol Clin North Am 2021
0

Progress and Challenges of Predictive Biomarkers for Immune Checkpoint Blockade.
Yanna Lei, Xiaoying Li, Qian Huang, Xiufeng Zheng, Ming Liu. Front Oncol 2021
3

Cutaneous Squamous Cell Carcinoma in the Age of Immunotherapy.
Yosuke Ishitsuka, Yuma Hanaoka, Atsushi Tanemura, Manabu Fujimoto. Cancers (Basel) 2021
2

7

Systematic Assessment of Transcriptomic Biomarkers for Immune Checkpoint Blockade Response in Cancer Immunotherapy.
Shangqin Sun, Liwen Xu, Xinxin Zhang, Lin Pang, Zhilin Long, Chunyu Deng, Jiali Zhu, Shuting Zhou, Linyun Wan, Bo Pang,[...]. Cancers (Basel) 2021
0

Molecular determinants of response to PD-L1 blockade across tumor types.
Romain Banchereau, Ning Leng, Oliver Zill, Ethan Sokol, Gengbo Liu, Dean Pavlick, Sophia Maund, Li-Fen Liu, Edward Kadel, Nicole Baldwin,[...]. Nat Commun 2021
4

Combinatorial therapy in tumor microenvironment: Where do we stand?
Smita Kumari, Dia Advani, Sudhanshu Sharma, Rashmi K Ambasta, Pravir Kumar. Biochim Biophys Acta Rev Cancer 2021
1